Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Clinical trial NCT00817739 · COMPLETED

Trial details

NCT number: NCT00817739
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 1996-12-01
Primary completion: 2005-09-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.